Ousia Pharma, a Danish biotech start-up, is at the forefront of innovative therapeutic strategies with their groundbreaking use of peptide-drug-conjugates. Derived from the Greek word for essence, Ousia Pharma represents the core of their mission: to transform the lives of patients suffering from metabolic and cognitive disorders. Utilizing a targeted approach, Ousia Pharma develops novel peptide-drug conjugates aimed at treating cognitive disorders and metabolic diseases.

By leveraging peptides, they successfully deliver modulators of synaptic plasticity to the brain, revolutionizing the field of biotechnology. Led by a team of renowned experts in neuroscience, molecular metabolism, and medicinal chemistry, Ousia Pharma's collective knowledge ensures the development of effective and safe pharmacotherapies. Combining academic expertise with industrial research experience, their researchers strive to create transformative therapies that improve the health and well-being of patients worldwide.

With a commitment to advancing healthcare, Ousia Pharma is carving a path towards a brighter future. Stay connected with them on LinkedIn to witness their impactful journey unfold